How to Stop Taking Wegovy Safely: a Step-by-Step Guide

Step 1: talk to your prescriber before you stop, not after

The most common misconception is that Wegovy is like a vitamin you can simply set aside whenever you choose. It is not that straightforward. Semaglutide is a prescription medicine that affects appetite signalling, gastric emptying, and blood glucose regulation, and stopping without a conversation leaves you without a plan for any of those.

Your prescriber will want to know why you are considering stopping. Reasons vary enormously: side effects that have not settled, a planned pregnancy, surgery, cost, reaching a stable weight, or simply wanting a break. Each has a different clinical implication. Someone stopping because of persistent nausea needs different advice from someone stopping because they have hit their target weight. The process of coming off Wegovy safely really does depend on the reason.

If surgery is involved, tell your anaesthetist and surgical team too. NHS England's guidance on weight-management injections explicitly advises informing your whole healthcare team, including the anaesthetist, before any procedure. Wegovy affects gastric emptying and there are important considerations around aspiration risk under general anaesthetic.

Do not skip this conversation to save time. A five-minute exchange with a prescriber can prevent weeks of unmanaged hunger and avoidable weight regain.

Step 2: understand what the medicine has been doing — and what stops when you stop

Semaglutide works by activating GLP-1 receptors that regulate appetite and slow how quickly food leaves the stomach. It is this mechanism that makes meals feel satisfying at smaller portions. When you stop, those receptors return to their baseline state. For most people that means hunger increases, satiety arrives later in a meal, and cravings that had been muted come back.

The STEP 1 trial, published in the New England Journal of Medicine, followed participants who discontinued semaglutide 2.4mg after 68 weeks. By one year after stopping, participants had regained approximately two-thirds of the weight they had lost. This is not a failure of willpower; it reflects the biology of a chronic condition that the medicine was managing. Understanding this before stopping helps set realistic expectations rather than leading to a demoralising surprise.

The half-life of semaglutide is approximately one week, so the medicine clears slowly. Some people notice appetite changes within a week of missing a dose; for others the shift is more gradual over the second and third week. If you want to track how your body responds when Wegovy clears, keeping a simple food diary in the first fortnight is practical and informative.

Step 3: build the bridge, what to put in place before the last injection

The weeks before stopping are more useful than the weeks after. A prescriber or dietitian can help you set a calorie and protein intake that supports the weight you have reached, because semaglutide will no longer be doing that work passively. Protein adequacy and regular resistance activity are the two factors most consistently associated with maintaining weight after stopping a GLP-1 medicine, according to NHS guidance on healthy weight maintenance.

Meal structure matters more once appetite suppression fades. Many people find that three structured meals (rather than relying on the medicine to suppress grazing) help manage energy intake. This is not about rigid dieting; it is about replacing one regulatory mechanism with another.

For some people, stepping down the dose gradually over one or two dose levels feels more comfortable than stopping at the maintenance dose. There is no universal clinical mandate for this, but your prescriber can advise based on your current dose and how you have tolerated changes in the past. If you are already on a lower dose and have been wondering about stopping Wegovy specifically for weight-loss management, that context changes the conversation slightly.

Step 4: monitor and know when to get help

Most people stop Wegovy without any acute medical event. That said, there are things worth watching. Blood sugar is one: if you have type 2 diabetes or prediabetes, your prescriber will want to review your glucose management because semaglutide has a glucose-lowering effect that will no longer be present. Blood pressure and lipids may also shift over weeks to months after stopping, particularly if significant weight is regained.

Mood is worth mentioning too. Some people notice a dip in mood during and after stopping GLP-1 medicines; the mechanism is not fully established, but it is worth flagging to your GP or prescriber if low mood or changes in mental health persist for more than a couple of weeks.

If you experience any symptom that concerns you at any point (including severe stomach pain, persistent vomiting, or symptoms of an allergic reaction) contact your GP or call 111. The MHRA's Yellow Card scheme lets anyone report a suspected side effect, including reactions noticed after stopping a medicine.

Thinking about whether treatment is still right for you, or whether restarting makes sense later? The question of whether you can pause and restart is worth exploring with a prescriber rather than assuming one way or the other. And if cost has been a factor in your thinking, understanding what drives Wegovy pricing in the UK may also be useful context before making a final decision.

If you would like a clinician to review where you are and help you plan the next step, check your eligibility with our team. A GPhC-registered prescriber reads every consultation the same day.